Frontier Wealth Management LLC Mustang Bio, Inc. Transaction History

Frontier Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$2.57 - $4.08 $128,499 - $204,000	-50,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.74 - $4.65 $56,142 - $95,278	20,490 Added 69.43%	50,000 $163,000
Q1 2019 May 15, 2019	BUY	$2.95 - $5.61 $11,800 - $22,440	4,000 Added 15.68%	29,510 $101,000
Q1 2018 May 15, 2018	BUY	$10.14 - $12.38 $258,671 - $315,813	25,510 New	25,510 $279,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $23.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.